A mesoporous silica nanoparticle – PEI – Fusogenic peptide system for siRNA delivery in cancer therapy
- 31 January 2013
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 34 (4), 1391-1401
- https://doi.org/10.1016/j.biomaterials.2012.10.072
Abstract
No abstract availableKeywords
Funding Information
- ERC (11DZ2211000)
- NNSF (30900756, 81000656)
- SJTU (YG2009ZD203, YG2010ZD102, YG2011MS44, AE4160003)
- SJTU (Z-416-001)
This publication has 45 references indexed in Scilit:
- Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatmentInternational Journal of Pharmaceutics, 2010
- All‐in‐One Target‐Cell‐Specific Magnetic Nanoparticles for Simultaneous Molecular Imaging and siRNA DeliveryAngewandte Chemie-International Edition, 2009
- Knocking down barriers: advances in siRNA deliveryNature Reviews Drug Discovery, 2009
- Polymer-based siRNA delivery: Perspectives on the fundamental and phenomenological distinctions from polymer-based DNA deliveryJournal of Controlled Release, 2007
- RNAi therapeutics: Principles, prospects and challengesAdvanced Drug Delivery Reviews, 2007
- Lipid-based Nanoparticles for Nucleic Acid DeliveryPharmaceutical Research, 2007
- Lipidic Carriers of siRNA: Differences in the Formulation, Cellular Uptake, and Delivery with Plasmid DNABiochemistry, 2004
- Killing the messenger: short RNAs that silence gene expressionNature Reviews Molecular Cell Biology, 2003
- Lentivirus-delivered stable gene silencing by RNAi in primary cellsRNA, 2003
- Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature, 1998